1800 202 8726
Sarcoma chemotherapy

Doxorubicin and Ifosfamide: — The AI Regimen for Sarcoma

If your chart says 'AI regimen', it means treatment with doxorubicin and ifosfamide — two chemotherapy drugs given together for soft tissue sarcoma. This regimen is intensive, almost always requires a hospital stay, and the name alone leaves many questions unanswered.

  • Two drugs, not one — AI stands for Adriamycin (doxorubicin) and Ifosfamide — two chemotherapy drugs given in the same course of treatment.
  • Usually an inpatient stay — Ifosfamide is given as a continuous infusion over several days, which means most people are admitted to hospital for each cycle.
  • A third medicine protects the bladder — Mesna is given alongside ifosfamide at every cycle. It is not chemotherapy — it prevents bladder damage from ifosfamide.
  • Planned in cycles — Treatment is given in repeated courses separated by rest periods, with blood tests and review before each cycle starts.

Medically reviewed by Dr. Naresh Gundu, Medical Oncologist, MBBS (Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar) · DNB Internal Medicine (Sir Gangaram Hospital, New Delhi) · DM Medical Oncology (AIIMS) · Last reviewed September 2026

Prescription-only medicine. Doxorubicin and ifosfamide are prescription-only medicines given only under the direct supervision of a specialist oncologist in a clinical setting. Nothing on this page can be used to start, change or stop treatment. Nothing on this page is a recommendation to use this medicine. It is not suitable for most patients — see "Who this is not for" below.

Ask about your own treatment

A senior medical oncologist reviews what you send and replies in writing.

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.

The AI regimen combines doxorubicin (also called Adriamycin) and ifosfamide, two chemotherapy drugs used for soft tissue sarcoma. Because ifosfamide is given as a continuous intravenous infusion over several days, this regimen is almost always given during a hospital admission, not as a day-care visit.

What are doxorubicin and ifosfamide, and why are they given together?

Doxorubicin is an anthracycline chemotherapy drug, sometimes referred to by its older brand name Adriamycin. It interferes with the way cancer cells copy their DNA, which prevents them from dividing. Ifosfamide is an alkylating agent that damages cancer cell DNA at a different point in the replication cycle.

Using both drugs together aims to attack sarcoma cells through more than one mechanism at the same time.

A third medicine, mesna, is given alongside ifosfamide at every cycle. Mesna is not chemotherapy — it protects the lining of the bladder from a toxic breakdown product that ifosfamide produces as it is processed by the body.

What do the terms on your paperwork mean?

AI regimen
The combination of doxorubicin and ifosfamide used to treat certain soft tissue sarcomas. AI comes from Adriamycin (doxorubicin) and Ifosfamide.
Doxorubicin (Adriamycin)
An anthracycline chemotherapy drug that interferes with DNA replication in cancer cells. Given intravenously.
Ifosfamide
An alkylating chemotherapy agent given as a continuous intravenous infusion over several days, which is why hospital admission is needed.
Mesna
A protective medicine given at every ifosfamide cycle. It is not chemotherapy — it prevents bladder damage from ifosfamide's toxic breakdown product.
Cycle
One complete course of treatment followed by a rest period. The number of cycles and the interval between them is decided individually by your oncologist.

Who should not receive doxorubicin and ifosfamide

Doxorubicin and ifosfamide are not appropriate for everyone with sarcoma. Several conditions make one or both drugs unsafe.

This regimen is generally not used in people who have:

  • Significantly reduced heart function — doxorubicin is directly toxic to the heart muscle, and pre-existing weakness increases the risk of serious cardiac damage
  • Severely impaired kidney function — ifosfamide is cleared through the kidneys and accumulates to harmful levels when they are not working adequately
  • Pre-existing ifosfamide encephalopathy or significant neurological impairment
  • Active severe infection, as the regimen substantially suppresses the immune system
  • Pregnancy — both drugs carry significant risks to a developing fetus
  • Severely reduced bone marrow reserve that cannot safely withstand intensive suppression

Eligibility is decided by an oncologist on each individual case, taking into account the person's full medical history, organ function, and the specific sarcoma being treated.

Why does the AI regimen usually need a hospital admission?

Ifosfamide is given as a continuous intravenous infusion over several days, not as a short injection that can be completed in a few hours. That alone makes day-care delivery impractical for most people.

During the admission your team monitors for ifosfamide encephalopathy — a neurological side effect that can cause confusion or unusual drowsiness — and for rapid changes in blood counts. Both are manageable when caught early.

Continuous intravenous hydration is also given alongside the ifosfamide to protect the kidneys and support the action of mesna. That hydration adds to the time needed.

What are the main effects of the AI regimen on the body?

How does doxorubicin affect the heart?

Doxorubicin can damage the heart muscle over time. The risk increases with the total amount received across all cycles, so there is a lifetime cumulative limit. Your heart function is checked with an echocardiogram or MUGA scan before and periodically during treatment. If function falls below a safe threshold, the dose may need to be adjusted or doxorubicin stopped. Tell your team about any breathlessness, palpitations, or ankle swelling.

What is ifosfamide encephalopathy, and what does it look like?

Ifosfamide encephalopathy occurs in a proportion of patients. It can cause confusion, unusual sleepiness, agitation, or difficulty speaking — typically during or shortly after the infusion. In most cases symptoms resolve when the drug is stopped and treatment is given. Your nursing team will check your alertness and orientation regularly during the infusion, which is one reason continuous observation matters.

What happens to blood counts?

Both drugs reduce the bone marrow's production of white blood cells, red blood cells and platelets. The lowest point — the nadir — occurs in the days to weeks after each cycle, before counts recover. Your team will schedule blood tests to monitor this. Low white cells increase infection risk, low red cells cause fatigue and breathlessness, and low platelets increase bleeding risk.

Will I lose my hair?

Doxorubicin causes hair loss in most people who receive it. Loss usually begins within the first few weeks and can include scalp hair, eyebrows and body hair. Hair regrows after treatment ends, though texture and thickness sometimes change temporarily. A cold cap reduces loss with some chemotherapy drugs but is generally less effective with doxorubicin — ask your team whether it is available at your centre.

What are the risks to the kidneys and bladder?

Ifosfamide produces a breakdown product that is toxic to the bladder lining. Mesna, given at the same time, neutralises it. Ifosfamide can also affect kidney tubule function over repeated cycles, so kidney blood tests are checked before each course. Tell your team immediately if you see blood in your urine during or after treatment.

How is nausea managed during the admission?

Nausea and vomiting are common with both drugs. Anti-nausea medicines are given before and during chemotherapy and continued as tablets after the infusion ends. Most people find nausea manageable with these medicines, though appetite may remain poor for several days after each cycle. Mouth soreness can also occur and tends to peak in the first week after treatment. Your ward team will advise on mouth care.

Explore 82 more How Chemotherapy Is Given: Regimens, Cycles & Infusion Days topics

HUB — Chemotherapy Regimens

HUB — Cycles, Schedules and What Happens on Infusion Day

All How Chemotherapy Is Given: Regimens, Cycles & Infusion Days →

Common questions

Frequently asked questions

How many cycles of the AI regimen are typically given?

There is no single answer — the number depends on your sarcoma type, how your disease responds, and how well your body tolerates the treatment. Most planned courses involve several cycles, but your oncologist will review imaging and blood results before each one and may revise the plan in either direction. Think of the cycle count as a working plan rather than a fixed commitment.

Can the AI regimen ever be given as a day-care infusion?

Rarely, and only in specific circumstances. Ifosfamide requires continuous infusion over several days with concurrent hydration, mesna, and monitoring for encephalopathy — a combination that makes full outpatient delivery difficult. Some centres use an adapted schedule that shortens the admission, but the monitoring requirements remain. Your oncologist will explain exactly what is planned for your situation.

What sarcomas is the AI regimen used for?

The AI regimen is used for soft tissue sarcomas. NCCN guidelines list it among regimens for various histological subtypes in both locally advanced and metastatic settings. It is not used for all sarcoma types — gastrointestinal stromal tumours, for example, are treated with targeted agents rather than conventional chemotherapy. Your oncologist will tell you whether this regimen fits your specific diagnosis.

What happens between hospital cycles?

You go home and daily activity gradually returns as your body recovers. The period of lowest blood counts — and highest infection risk — typically falls in the middle of each rest period. Blood tests are checked at an outpatient appointment around that time. If you develop a fever, feel suddenly unwell, or notice unexpected bleeding, contact your team or go to the emergency department without waiting.

How long is each hospital admission?

Most admissions last several days, depending on the ifosfamide schedule being used and how you respond. Some people need a longer stay if complications such as encephalopathy develop. The discharge decision is made on your clinical state rather than a fixed timetable. It is worth planning for some flexibility when arranging support at home.

What should I do if I get a fever after going home?

Contact your oncology team or go to the nearest emergency department immediately, and tell them you have recently had chemotherapy. A fever after this regimen is treated as a potential infection emergency, because bone marrow suppression means your body cannot fight infection normally. Do not take paracetamol and wait for it to settle. This applies for the weeks following each cycle, not only the first day or two after discharge.

Full index

Browse all 579 chemotherapy topics

Every page in this section, grouped by the part of treatment it belongs to. Open a group to see what is in it.

Before You Start: Tests, Ports & Fertility42
Blood Counts, Infection, Fever & Emergencies73

Anaemia & Low Haemoglobin

HUB — Low Blood Counts, Infection and Fever During Chemotherapy

Chemotherapy and Supportive Medicines by Name75

Chemotherapy Drugs by Name

HUB — Chemotherapy Drugs by Name

HUB — Generic, Branded and Biosimilar Chemotherapy in India

HUB — Supportive Medicines Used With Chemotherapy

Chemotherapy at CION Cancer Clinics1
Chemotherapy by Cancer Type and Special Situations5

Special Populations & Comorbidities

HUB — Chemotherapy in Special Situations

Chemotherapy in Hyderabad: Cost, Centres & Access93

HUB — Choosing a Chemotherapy Centre and Safe Administration

Common Side Effects and How They Are Managed78
Food, Diet, Hydration & Household Safety6
How Chemotherapy Is Given: Regimens, Cycles & Infusion Days85

Other Ways Chemotherapy Is Given

HUB — Cycles, Schedules and What Happens on Infusion Day

Is It Working, Finishing Chemotherapy & Survivorship7

Is It Working? Response & Scans

HUB — Is Chemotherapy Working? Scans and Response

HUB — When Chemotherapy Stops Working

Nerve, Skin, Heart, Kidney and Cognitive Effects5

Skin, Nails & Hand-Foot Syndrome

Heart, Lung & Organ Toxicity

HUB — Effects on the Heart, Kidneys, Liver and Nerves

Understanding Chemotherapy, Myths & Trials97

HUB — Chemotherapy Myths and Alternative Treatment Claims

HUB — Clinical Trials in Cancer Treatment

HUB — What Is Chemotherapy and Why Has It Been Advised?

Work, Family, Relationships and Emotional Support12